CONNECT WITH US
Web3 & Blockchain

Web3 & Blockchain

INJ Price Prediction: rebound holds, but $7.92 remains the line to clear

Blockchain.News logo

Published on

Add as a preferred source on Google
INJ Price Prediction: rebound holds, but $7.92 remains the line to clear

Injective (INJ) rose 8.98% in the past 24 hours to $7.64, with Binance spot volume at $9,682,508. The move improved the short-term tone, but the price is still trading below the 20-day average and ...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

Injective (INJ) is up 8.98% over the past 24 hours and was trading at $7.64 in the supplied Binance spot data. The 24-hour range was $7.68 to $6.96, and volume reached $9,682,508. That leaves the token above the 7-day simple moving average of $7.26, but still below the 20-day SMA of $7.92 and very close to the 50-day SMA of $7.68, which keeps the trend mixed rather than decisively bullish.

The latest bounce has improved the tape, but the surrounding indicators do not yet confirm a clean trend change. The daily RSI is 50.05, which sits in neutral territory. MACD is slightly negative at -0.1135, with the signal line also at -0.1135 and the histogram essentially flat at -0.0000. Stochastic %K at 44.97 and %D at 35.97 also suggest the market is neither stretched nor oversold. Taken together, the evidence points to recovery, not confirmation.

The supplied technical levels frame the current setup clearly. 14. 71. 92 overlaps with the 20-day SMA, so that zone is the most important area to reclaim if the recent move is going to improve into something more durable. 72 is close to strong support, which reinforces that downside risk remains defined if the bounce fades.


Source link
Related Topics:Web3 & Blockchain

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.